ClinicalTrials.gov
ClinicalTrials.gov Menu

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00261313
Recruitment Status : Completed
First Posted : December 5, 2005
Last Update Posted : February 26, 2010
Sponsor:
Information provided by:
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2007
  Actual Study Completion Date : December 2007